Influenza Diagnostics Market by Test Type (Traditional Diagnostic Test and Molecular Diagnostic Test), by End-user (Hospital, Clinical Laboratories, and Other End-Users), Geography (North America, Europe, APAC, and RoW) - Forecast to 2026
Influenza Diagnostics Market by Test Type (Traditional Diagnostic Test and Molecular Diagnostic Test), by End-user (Hospital, Clinical Laboratories, and Other End-Users), Geography (North America, Europe, APAC, and RoW) - Forecast to 2026
Influenza is a highly contagious disease caused by the influenza virus attacking the respiratory system - lungs, nose, and throat, which causes illness. This can also lead to the death of the infected person. Influenza diagnostics tests enable to identify the virus in the body.
Research Methodology:
The influenza diagnostics market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below
The factors pushing the market growth forward are the globally increasing cases of influenza, the given preference for quick diagnosis, an increasing elderly population where the chances of effecting are high, and the advancements in the diagnosis & various tests. In addition, the developing advanced genomics and proteomics technology also fuel the demand. Although some aspects, such as increasing hospital expenses, the discrepancy in the test sensitivity & test specificity, and restricted regulations are hampering the influenza diagnostics market growth. Globally, a major factor affecting the market is the present COVID-19 Pandemic situation. The COVID-19 is also a contagious disease where the virus is attacking the respiratory system, and the influenza tests are increasing due to this pandemic. Influenza Diagnostics Market is predicted to grow at a CAGR of 6.3% during the forecasting period market is expected to grow from $4.0 billion in 2020 to a value of $5.8 billion in 2026.
Influenza Diagnostics Market study is segmented by test type, end-user, and geography.
Based on Test type:
Traditional Diagnostic Tests
RIDT
Viral Culture
DFA
Serological assays
Molecular Diagnostic Tests
RT-PCR
INNAT
TMA
LAMP
NASBA
Other INNAT
Other Molecular Tests
Based on End-User:
Hospitals
Clinical Laboratories
Other End-User
Based on Geography:
North America
Europe
Asia Pacific
Rest of the World
Majorly, the RIDT diagnostic test in traditional diagnostics test is the most demanding segment based on the test type due to simple usage procedure and the low cost of diagnosis. Moreover, it is significant in the situation of a low-resource setting and also easy to read and less time-consuming procedure. Hence, the RIDT diagnostic test segment has the largest share in the influenza diagnostics market.
The majority of the influenza diagnostics market share is acquired by the hospital segment based on the end-users. However, the influenza tests are frequently carried by the hospitals due to its complicated nature and also require advanced technology products to carry the influenza diagnosis.
As per the geographical analysis, the market is segmented by North America, Europe, Asia Pacific, and the rest of the world. Compared to the other regions, North America has acquired the largest share in the market due to the rising incidence of respiratory diseases such as influenza and the increasing demand for the influenza screening test in this region. Asia Pacific region is estimated to have the fastest growth in the market with the rapidly increasing population, which is leading to the spread of contagious diseases while the government is stepping up its initiatives to reduce the spread of contagious diseases.
Globally, the contagious diseases are increasing; hence, the influenza diagnostics enable to identify influenza the most contagious disease. Majorly two factors emphasizing the influenza diagnostics market growth are the increasing elderly population as the old generation is weak, and lack of immunity can cause influenza and the increasing investments in influenza diagnostic research. Somehow, the rising cost of kits and reagents in the influenza diagnostics is the major aspect hindering the market growth.
The major players who are competing in the influenza diagnostics market are Quidel Corporation, Inc, Abbott Laboratories, Inc., Hologic, Inc, Becton, Dickinson and Company, Danaher CORPORATION, Diasorin sa, Meridian Bioscience, Luminex Corporation, Biom?rieux sa, Genmark Diagnostics, Inc, Siemens Healthineers, Thermo Fisher Scientific, Tecan Trading, Sekisui Diagnostics, F. Hoffmann-la Roche AG, SA Scientific, Ltd, Altona Diagnostics GMBH, Coris Bioconcept SPRL and Elitech Group.
Moreover, the advancements in technology and the innovations in developing the quick, precise, and low-cost diagnosis for diseases is the major aspect creating an opportunity for the influenza diagnostics market players. This report gives an in-depth analysis of the drivers, challenges, and opportunities of the influenza diagnostics market.
The analysis based on the segmentation such as test type, end-users and geography is provided in this report
This report also provides the strengths and weaknesses, portfolio analysis, capability analysis of the leading players
The report will also help the research organization of influenza diagnostics to support their research in the advancements in the tests for the better diagnosis
Quantitative analysis of the market enables users to understand the contribution of the major regions in the market growth.
Influenza is a highly contagious disease caused by the influenza virus attacking the respiratory system - lungs, nose, and throat, which causes illness. This can also lead to the death of the infected person. Influenza diagnostics tests enable to identify the virus in the body.
Research Methodology:
The influenza diagnostics market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below
The factors pushing the market growth forward are the globally increasing cases of influenza, the given preference for quick diagnosis, an increasing elderly population where the chances of effecting are high, and the advancements in the diagnosis & various tests. In addition, the developing advanced genomics and proteomics technology also fuel the demand. Although some aspects, such as increasing hospital expenses, the discrepancy in the test sensitivity & test specificity, and restricted regulations are hampering the influenza diagnostics market growth. Globally, a major factor affecting the market is the present COVID-19 Pandemic situation. The COVID-19 is also a contagious disease where the virus is attacking the respiratory system, and the influenza tests are increasing due to this pandemic. Influenza Diagnostics Market is predicted to grow at a CAGR of 6.3% during the forecasting period market is expected to grow from $4.0 billion in 2020 to a value of $5.8 billion in 2026.
Influenza Diagnostics Market study is segmented by test type, end-user, and geography.
Based on Test type:
Traditional Diagnostic Tests
RIDT
Viral Culture
DFA
Serological assays
Molecular Diagnostic Tests
RT-PCR
INNAT
TMA
LAMP
NASBA
Other INNAT
Other Molecular Tests
Based on End-User:
Hospitals
Clinical Laboratories
Other End-User
Based on Geography:
North America
Europe
Asia Pacific
Rest of the World
Majorly, the RIDT diagnostic test in traditional diagnostics test is the most demanding segment based on the test type due to simple usage procedure and the low cost of diagnosis. Moreover, it is significant in the situation of a low-resource setting and also easy to read and less time-consuming procedure. Hence, the RIDT diagnostic test segment has the largest share in the influenza diagnostics market.
The majority of the influenza diagnostics market share is acquired by the hospital segment based on the end-users. However, the influenza tests are frequently carried by the hospitals due to its complicated nature and also require advanced technology products to carry the influenza diagnosis.
As per the geographical analysis, the market is segmented by North America, Europe, Asia Pacific, and the rest of the world. Compared to the other regions, North America has acquired the largest share in the market due to the rising incidence of respiratory diseases such as influenza and the increasing demand for the influenza screening test in this region. Asia Pacific region is estimated to have the fastest growth in the market with the rapidly increasing population, which is leading to the spread of contagious diseases while the government is stepping up its initiatives to reduce the spread of contagious diseases.
Globally, the contagious diseases are increasing; hence, the influenza diagnostics enable to identify influenza the most contagious disease. Majorly two factors emphasizing the influenza diagnostics market growth are the increasing elderly population as the old generation is weak, and lack of immunity can cause influenza and the increasing investments in influenza diagnostic research. Somehow, the rising cost of kits and reagents in the influenza diagnostics is the major aspect hindering the market growth.
The major players who are competing in the influenza diagnostics market are Quidel Corporation, Inc, Abbott Laboratories, Inc., Hologic, Inc, Becton, Dickinson and Company, Danaher CORPORATION, Diasorin sa, Meridian Bioscience, Luminex Corporation, Biom?rieux sa, Genmark Diagnostics, Inc, Siemens Healthineers, Thermo Fisher Scientific, Tecan Trading, Sekisui Diagnostics, F. Hoffmann-la Roche AG, SA Scientific, Ltd, Altona Diagnostics GMBH, Coris Bioconcept SPRL and Elitech Group.
Moreover, the advancements in technology and the innovations in developing the quick, precise, and low-cost diagnosis for diseases is the major aspect creating an opportunity for the influenza diagnostics market players. This report gives an in-depth analysis of the drivers, challenges, and opportunities of the influenza diagnostics market.
The analysis based on the segmentation such as test type, end-users and geography is provided in this report
This report also provides the strengths and weaknesses, portfolio analysis, capability analysis of the leading players
The report will also help the research organization of influenza diagnostics to support their research in the advancements in the tests for the better diagnosis
Quantitative analysis of the market enables users to understand the contribution of the major regions in the market growth.
Executive Summary
Industry Outlook
Industry Overview
Industry Trends
Market Snapshot
Market Definition
Market Outlook
PEST Analysis
Porter Five Forces
Related Markets
Market characteristics
Market Evolution
Market Trends and Impact
Advantages/Disadvantages of Market
Regulatory Impact
Market Offerings
Market Segmentation
Market Dynamics
Drivers
Restraints
Opportunities
DRO - Impact Analysis
End-user: Market Size & Analysis
Overview
Traditional Diagnostic Tests
RIDT
Viral Culture
DFA
Serological assays
Molecular Diagnostic Tests
RT-PCR
INNAT
TMA
LAMP
NASBA
Other INNAT
5.3.3 Other Molecular Tests
End-User: Market Size & Analysis
Overview
Hospitals
Clinical Laboratories
Other End-User
Geography: Market Size & Analysis
Overview
North America
Europe
Asia Pacific
Rest of the World
Competitive Landscape
Competitor Comparison Analysis
Market Developments
Mergers and Acquisitions, Legal, Awards, Partnerships
Product Launches and execution
Vendor Profiles
F. HOFFMANN-LA ROCHE AG
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
QUIDEL CORPORATION
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
THERMO FISHER SCIENTIFIC, INC
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
ABBOTT LABORATORIES, INC.
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
HOLOGIC, INC
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
BECTON, DICKINSON AND COMPANY
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
DANAHER CORPORATION
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
DIASORIN SA
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
MERIDIAN BIOSCIENCE
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
LUMINEX CORPORATION
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Companies to Watch
BIOM?RIEUX SA
Overview
Market
Business Strategy
GENMARK DIAGNOSTICS, INC
Overview
Market
Business Strategy
SIEMENS HEALTHINEERS
Overview
Market
Business Strategy
TECAN TRADING
Overview
Market
Business Strategy
SEKISUI DIAGNOSTICS
Overview
Market
Business Strategy
SA SCIENTIFIC, LTD
Overview
Market
Business Strategy
ALTONA DIAGNOSTICS GMBH
Overview
Market
Business Strategy
CORIS BIOCONCEPT SPRL
Overview
Market
Business Strategy
ELITECH GROUP
Overview
Market
Business Strategy
Analyst Opinion
Annexure
Report Scope
Market Definitions
Research Methodology
Data Collation and In-house Estimation
Market Triangulation
Forecasting
Report Assumptions
Declarations
Stakeholders
Abbreviations
Industry Outlook
Industry Overview
Industry Trends
Market Snapshot
Market Definition
Market Outlook
PEST Analysis
Porter Five Forces
Related Markets
Market characteristics
Market Evolution
Market Trends and Impact
Advantages/Disadvantages of Market
Regulatory Impact
Market Offerings
Market Segmentation
Market Dynamics
Drivers
Restraints
Opportunities
DRO - Impact Analysis
End-user: Market Size & Analysis
Overview
Traditional Diagnostic Tests
RIDT
Viral Culture
DFA
Serological assays
Molecular Diagnostic Tests
RT-PCR
INNAT
TMA
LAMP
NASBA
Other INNAT
5.3.3 Other Molecular Tests
End-User: Market Size & Analysis
Overview
Hospitals
Clinical Laboratories
Other End-User
Geography: Market Size & Analysis
Overview
North America
Europe
Asia Pacific
Rest of the World
Competitive Landscape
Competitor Comparison Analysis
Market Developments
Mergers and Acquisitions, Legal, Awards, Partnerships
Product Launches and execution
Vendor Profiles
F. HOFFMANN-LA ROCHE AG
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
QUIDEL CORPORATION
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
THERMO FISHER SCIENTIFIC, INC
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
ABBOTT LABORATORIES, INC.
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
HOLOGIC, INC
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
BECTON, DICKINSON AND COMPANY
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
DANAHER CORPORATION
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
DIASORIN SA
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
MERIDIAN BIOSCIENCE
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
LUMINEX CORPORATION
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Companies to Watch
BIOM?RIEUX SA
Overview
Market
Business Strategy
GENMARK DIAGNOSTICS, INC
Overview
Market
Business Strategy
SIEMENS HEALTHINEERS
Overview
Market
Business Strategy
TECAN TRADING
Overview
Market
Business Strategy
SEKISUI DIAGNOSTICS
Overview
Market
Business Strategy
SA SCIENTIFIC, LTD
Overview
Market
Business Strategy
ALTONA DIAGNOSTICS GMBH
Overview
Market
Business Strategy
CORIS BIOCONCEPT SPRL
Overview
Market
Business Strategy
ELITECH GROUP
Overview
Market
Business Strategy
Analyst Opinion
Annexure
Report Scope
Market Definitions
Research Methodology
Data Collation and In-house Estimation
Market Triangulation
Forecasting
Report Assumptions
Declarations
Stakeholders
Abbreviations
LIST OF TABLES
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE, BY TEST TYPE, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR TRADITIONAL DIAGNOSTIC TESTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR RIDT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR VIRAL CULTURE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR DFA, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR SEROLOGICAL ASSAYS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR MOLECULAR DIAGNOSTIC TESTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR RT-PCR, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR INNAT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR TMA, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR LAMP, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR OTHER TEST, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR CLINICAL LABORATORIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR OTHER END-USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
NORTH AMERICA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.S INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.S INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CANADA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CANADA INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
EUROPE INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GERMANY INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GERMANY INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.K INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.K INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ROE INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ROE INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHINA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
INDIA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
REST OF WORLD INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
F. HOFFMANN-LA ROCHE AG.: OVERVIEW
F. HOFFMANN-LA ROCHE AG.: STRATEGIC SNAPSHOT
F. HOFFMANN-LA ROCHE AG.: BUSINESS OPPORTUNITIES AND OUTLOOK
F. HOFFMANN-LA ROCHE AG.: TEST TYPE/SERVICE PORTFOLIO
QUIDEL CORPORATION: OVERVIEW
QUIDEL CORPORATION: STRATEGIC SNAPSHOT
QUIDEL CORPORATION: BUSINESS OPPORTUNITIES AND OUTLOOK
QUIDEL CORPORATION: TEST TYPE/SERVICE PORTFOLIO
THERMO FISHER SCIENTIFIC, INC: OVERVIEW
THERMO FISHER SCIENTIFIC, INC: STRATEGIC SNAPSHOT
THERMO FISHER SCIENTIFIC, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
THERMO FISHER SCIENTIFIC, INC: TEST TYPE/SERVICE PORTFOLIO
ABBOTT LABORATORIES, INC..: OVERVIEW
ABBOTT LABORATORIES, INC..: STRATEGIC SNAPSHOT
ABBOTT LABORATORIES, INC..: BUSINESS OPPORTUNITIES AND OUTLOOK
ABBOTT LABORATORIES, INC..: TEST TYPE/SERVICE PORTFOLIO
HOLOGIC, INC: OVERVIEW
HOLOGIC, INC: STRATEGIC SNAPSHOT
HOLOGIC, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
HOLOGIC, INC: TEST TYPE/SERVICE PORTFOLIO
BECTON, DICKINSON AND COMPANY.: OVERVIEW
BECTON, DICKINSON AND COMPANY.: STRATEGIC SNAPSHOT
BECTON, DICKINSON AND COMPANY.: BUSINESS OPPORTUNITIES AND OUTLOO
BECTON, DICKINSON AND COMPANY.: TEST TYPE/SERVICE PORTFOLIO
DANAHER CORPORATION: OVERVIEW
DANAHER CORPORATION: STRATEGIC SNAPSHOT
DANAHER CORPORATION: BUSINESS OPPORTUNITIES AND OUTLOOK
DANAHER CORPORATION: TEST TYPE/SERVICE PORTFOLIO
DIASORIN SA: OVERVIEW
DIASORIN SA: STRATEGIC SNAPSHOT
DIASORIN SA: BUSINESS OPPORTUNITIES AND OUTLOOK
DIASORIN SA: TEST TYPE/SERVICE PORTFOLIO
MERIDIAN BIOSCIENCE: OVERVIEW
MERIDIAN BIOSCIENCE: STRATEGIC SNAPSHOT
MERIDIAN BIOSCIENCE: BUSINESS OPPORTUNITIES AND OUTLOOK
MERIDIAN BIOSCIENCE: TEST TYPE/SERVICE PORTFOLIO
LUMINEX CORPORATION.: OVERVIEW
LUMINEX CORPORATION.: STRATEGIC SNAPSHOT
LUMINEX CORPORATION.: BUSINESS OPPORTUNITIES AND OUTLO
LUMINEX CORPORATION.: TEST TYPE/SERVICE PORTFOLIO
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE, BY TEST TYPE, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR TRADITIONAL DIAGNOSTIC TESTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR RIDT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR VIRAL CULTURE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR DFA, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR SEROLOGICAL ASSAYS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR MOLECULAR DIAGNOSTIC TESTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR RT-PCR, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR INNAT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR TMA, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR LAMP, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR OTHER TEST, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR CLINICAL LABORATORIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR OTHER END-USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
NORTH AMERICA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.S INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.S INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CANADA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CANADA INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
EUROPE INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GERMANY INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GERMANY INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.K INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.K INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ROE INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ROE INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHINA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
INDIA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
REST OF WORLD INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
F. HOFFMANN-LA ROCHE AG.: OVERVIEW
F. HOFFMANN-LA ROCHE AG.: STRATEGIC SNAPSHOT
F. HOFFMANN-LA ROCHE AG.: BUSINESS OPPORTUNITIES AND OUTLOOK
F. HOFFMANN-LA ROCHE AG.: TEST TYPE/SERVICE PORTFOLIO
QUIDEL CORPORATION: OVERVIEW
QUIDEL CORPORATION: STRATEGIC SNAPSHOT
QUIDEL CORPORATION: BUSINESS OPPORTUNITIES AND OUTLOOK
QUIDEL CORPORATION: TEST TYPE/SERVICE PORTFOLIO
THERMO FISHER SCIENTIFIC, INC: OVERVIEW
THERMO FISHER SCIENTIFIC, INC: STRATEGIC SNAPSHOT
THERMO FISHER SCIENTIFIC, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
THERMO FISHER SCIENTIFIC, INC: TEST TYPE/SERVICE PORTFOLIO
ABBOTT LABORATORIES, INC..: OVERVIEW
ABBOTT LABORATORIES, INC..: STRATEGIC SNAPSHOT
ABBOTT LABORATORIES, INC..: BUSINESS OPPORTUNITIES AND OUTLOOK
ABBOTT LABORATORIES, INC..: TEST TYPE/SERVICE PORTFOLIO
HOLOGIC, INC: OVERVIEW
HOLOGIC, INC: STRATEGIC SNAPSHOT
HOLOGIC, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
HOLOGIC, INC: TEST TYPE/SERVICE PORTFOLIO
BECTON, DICKINSON AND COMPANY.: OVERVIEW
BECTON, DICKINSON AND COMPANY.: STRATEGIC SNAPSHOT
BECTON, DICKINSON AND COMPANY.: BUSINESS OPPORTUNITIES AND OUTLOO
BECTON, DICKINSON AND COMPANY.: TEST TYPE/SERVICE PORTFOLIO
DANAHER CORPORATION: OVERVIEW
DANAHER CORPORATION: STRATEGIC SNAPSHOT
DANAHER CORPORATION: BUSINESS OPPORTUNITIES AND OUTLOOK
DANAHER CORPORATION: TEST TYPE/SERVICE PORTFOLIO
DIASORIN SA: OVERVIEW
DIASORIN SA: STRATEGIC SNAPSHOT
DIASORIN SA: BUSINESS OPPORTUNITIES AND OUTLOOK
DIASORIN SA: TEST TYPE/SERVICE PORTFOLIO
MERIDIAN BIOSCIENCE: OVERVIEW
MERIDIAN BIOSCIENCE: STRATEGIC SNAPSHOT
MERIDIAN BIOSCIENCE: BUSINESS OPPORTUNITIES AND OUTLOOK
MERIDIAN BIOSCIENCE: TEST TYPE/SERVICE PORTFOLIO
LUMINEX CORPORATION.: OVERVIEW
LUMINEX CORPORATION.: STRATEGIC SNAPSHOT
LUMINEX CORPORATION.: BUSINESS OPPORTUNITIES AND OUTLO
LUMINEX CORPORATION.: TEST TYPE/SERVICE PORTFOLIO
LIST OF FIGURES
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE, BY TEST TYPE, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR TRADITIONAL DIAGNOSTIC TESTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR RIDT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR VIRAL CULTURE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR DFA, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR SEROLOGICAL ASSAYS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR MOLECULAR DIAGNOSTIC TESTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR RT-PCR, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR INNAT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR TMA, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR LAMP, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR OTHER TEST, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR CLINICAL LABORATORIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR OTHER END-USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
NORTH AMERICA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.S INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.S INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CANADA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CANADA INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
EUROPE INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GERMANY INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GERMANY INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.K INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.K INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ROE INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ROE INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHINA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
INDIA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
REST OF WORLD INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE, BY TEST TYPE, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR TRADITIONAL DIAGNOSTIC TESTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR RIDT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR VIRAL CULTURE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR DFA, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR SEROLOGICAL ASSAYS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR MOLECULAR DIAGNOSTIC TESTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR RT-PCR, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR INNAT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR TMA, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR LAMP, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR OTHER TEST, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR CLINICAL LABORATORIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL INFLUENZA DIAGNOSTICS MARKET VALUE FOR OTHER END-USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
NORTH AMERICA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.S INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.S INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CANADA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CANADA INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
EUROPE INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
EUROPE INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GERMANY INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GERMANY INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.K INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
U.K INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ROE INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ROE INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
ASIA PACIFIC INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHINA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
INDIA INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD INFLUENZA DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
REST OF WORLD INFLUENZA DIAGNOSTICS MARKET VALUE FOR TEST TYPE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
REST OF WORLD INFLUENZA DIAGNOSTICS MARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
